| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2293 |
| Trial ID | NCT04240808 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | UCD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL) |
| Year | 2020 |
| Country | United States |
| Company sponsor | University of Colorado, Denver |
| Other ID(s) | 19-2807 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||